# Information and Acceptability of Biosimilars

> **NCT04321291** · NA · UNKNOWN · sponsor: **University Hospital, Montpellier** · enrollment: 500 (estimated)

## Conditions studied

- Rheumatoid Arthritis
- Spondyloarthritis
- Psoriatic Arthritis

## Interventions

- **OTHER:** Generic information leaflet
- **OTHER:** Individual information by nurse on biosimilars

## Key facts

- **NCT ID:** NCT04321291
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-02
- **Primary completion:** 2023-11
- **Final completion:** 2023-11
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2023-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04321291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04321291, "Information and Acceptability of Biosimilars". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT04321291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*